From: Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
Time | Advances |
---|---|
1961 | Discovery of mRNA [14]. |
1969 | First in vitro translation of isolated mRNA [15]. |
1978 | Delivery of mRNA by using liposomes [16]. |
1984 | In vitro synthesis of biologically active RNA [17]. |
1989 | Development of cationic lipid-mediated mRNA delivery [18]. |
1990 | Demonstration that naked mRNA injected into mice is translated [19]. |
1992 | Injection of mRNA into rats for the treatment of diabetes insipidus [2]. |
1993 | Early reports of mRNA applications for infectious disease vaccines [20]. |
1995 | Early reports of mRNA applications for cancer vaccines [21]. |
2001 | First clinical trial of using mRNA-transfected dendritic cells in vitro [22]. |
2005 | Demonstration that nucleotide modification can reduce the immunogenicity of RNAs [23]. |
2010 | Generating iPSC by using mRNA [24]. |
2017 | First testing of a personalized mRNA cancer vaccine in humans [25]. |
2020 |